97 related articles for article (PubMed ID: 11151935)
1. Mycophenolate mofetil for therapy-resistant interstitial lung disease associated with ulcerative colitis.
Treiber G
Am J Gastroenterol; 2000 Dec; 95(12):3674-5. PubMed ID: 11151935
[No Abstract] [Full Text] [Related]
2. Mycophenolate mofetil therapy for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis.
Tsuchiya H; Tsuno H; Inoue M; Takahashi Y; Yamashita H; Kaneko H; Kano T; Mimori A
Mod Rheumatol; 2014 Jul; 24(4):694-6. PubMed ID: 24506658
[No Abstract] [Full Text] [Related]
3. Rheumatoid arthritis interstitial lung disease: mycophenolate mofetil as an antifibrotic and disease-modifying antirheumatic drug.
Saketkoo LA; Espinoza LR
Arch Intern Med; 2008 Aug; 168(15):1718-9. PubMed ID: 18695091
[No Abstract] [Full Text] [Related]
4. Interstitial lung disease as a presenting manifestation of microscopic polyangiitis successfully treated with mycophenolate mofetil.
Gómez-Puerta JA; Espinosa G; Morlà R; Cid MC; Cervera R
Clin Exp Rheumatol; 2009; 27(1):166-7. PubMed ID: 19327249
[No Abstract] [Full Text] [Related]
5. Mycophenolate mofetil for the patients with interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibodies.
Hayashi M; Kikuchi T; Takada T
Clin Rheumatol; 2017 Jan; 36(1):239-240. PubMed ID: 27718019
[No Abstract] [Full Text] [Related]
6. Treatment of pemphigus vulgaris with mycophenolate mofetil.
Enk AH; Knop J
Lancet; 1997 Aug; 350(9076):494. PubMed ID: 9274594
[No Abstract] [Full Text] [Related]
7. Mycophenolate mofetil as induction therapy after liver transplantation.
McDiarmid SV
Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S85-9. PubMed ID: 10431021
[No Abstract] [Full Text] [Related]
8. Mycophenolate mofetil for severe autoimmune haemolytic anemia.
Zimmer-Molsberger B; Knauf W; Thiel E
Lancet; 1997 Oct; 350(9083):1003-4. PubMed ID: 9329520
[No Abstract] [Full Text] [Related]
9. Mycophenolate mofetil, Crohn's disease, measles?
Altschuler EL
Am J Gastroenterol; 2000 Feb; 95(2):550-1. PubMed ID: 10685769
[No Abstract] [Full Text] [Related]
10. Mycophenolate mofetil therapy for juvenile dermatomyositis with immune thrombocytopenic purpura.
Ogimi C; Honma N; Tanaka R; Oh-ishi T
Mod Rheumatol; 2012 Apr; 22(2):280-3. PubMed ID: 21710356
[TBL] [Abstract][Full Text] [Related]
11. Use of mycophenolate mofetil to treat scleroderma-associated interstitial lung disease.
Zamora AC; Wolters PJ; Collard HR; Connolly MK; Elicker BM; Webb WR; King TE; Golden JA
Respir Med; 2008 Jan; 102(1):150-5. PubMed ID: 17822892
[TBL] [Abstract][Full Text] [Related]
12. Induction of inosine monophosphate dehydrogenase activity after long-term treatment with mycophenolate mofetil.
Sanquer S; Breil M; Baron C; Dhamane D; Astier A; Lang P
Clin Pharmacol Ther; 1999 Jun; 65(6):640-8. PubMed ID: 10391669
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of a patient with severe refractory myasthenia gravis using mycophenolate mofetil.
Hauser RA; Malek AR; Rosen R
Neurology; 1998 Sep; 51(3):912-3. PubMed ID: 9748061
[No Abstract] [Full Text] [Related]
14. Mycophenolate mofetil in the therapy of polymyositis associated with a polyautoimmune syndrome.
Schneider C; Gold R; Schäfers M; Toyka KV
Muscle Nerve; 2002 Feb; 25(2):286-8. PubMed ID: 11870700
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of inosine monophosphate dehydrogenase activity by the plasma of heart transplant recipients receiving mycophenolate mofetil.
Griesmacher A; Weigel G; Seebacher G; Mallinger R; Laufer G; Müller MM
Adv Exp Med Biol; 1998; 431():537-41. PubMed ID: 9598124
[No Abstract] [Full Text] [Related]
16. New immunosuppressive agents in clinical use: mycophenolate mofetil and tacrolimus.
Hunt SA
Cardiol Rev; 2000; 8(3):180-4. PubMed ID: 11174892
[TBL] [Abstract][Full Text] [Related]
17. Identification of a pharmacologically active metabolite of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil.
Schütz E; Shipkova M; Armstrong VW; Wieland E; Oellerich M
Clin Chem; 1999 Mar; 45(3):419-22. PubMed ID: 10053049
[No Abstract] [Full Text] [Related]
18. Effect of mycophenolate mofetil therapy on inosine monophosphate dehydrogenase induction in red blood cells of heart transplant recipients.
Weigel G; Griesmacher A; Zuckermann AO; Laufer G; Mueller MM
Clin Pharmacol Ther; 2001 Mar; 69(3):137-44. PubMed ID: 11240978
[TBL] [Abstract][Full Text] [Related]
19. A review of clinical experience with the novel immunosuppressive drug mycophenolate mofetil in renal transplantation.
Behrend M
Clin Nephrol; 1996 May; 45(5):336-41. PubMed ID: 8738667
[TBL] [Abstract][Full Text] [Related]
20. Consideration of mycophenolate mofetil for idiopathic pulmonary fibrosis.
Altschuler EL
Med Hypotheses; 2001 Dec; 57(6):701-2. PubMed ID: 11918429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]